8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Sep 8, 2021)

Filed September 8, 2021For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on September 8, 2021, to provide updated financial guidance. The company reaffirmed its net income guidance for the full year 2021, projecting it to be greater than $24.89 per share, which includes approximately $0.61 per share of net unfavorable items. Excluding these specific items, Elevance Health anticipates its adjusted net income to exceed $25.50 per share. This communication is primarily for informational purposes, reiterating previously disclosed expectations and does not include any new adjustments beyond those reported in the second quarter 2021 earnings release. Investors should note that this filing contains forward-looking statements and is subject to various risks and uncertainties that could cause actual results to differ materially from projections. The company urges a review of its SEC filings for a comprehensive understanding of these potential risks.

Key Highlights

  • 1Reaffirmed full-year 2021 net income guidance: greater than $24.89 per share.
  • 2Full-year 2021 guidance includes approximately $0.61 per share in net unfavorable items.
  • 3Expects adjusted net income for full-year 2021 to be greater than $25.50 per share.
  • 4Guidance does not incorporate any new adjustment items beyond those from Q2 2021 earnings.
  • 5The information was shared during investor meetings over the coming weeks.
  • 6The filing contains forward-looking statements subject to significant risks and uncertainties.
  • 7Investors are cautioned to review the company's SEC filings for detailed risk factors.

Frequently Asked Questions

The primary purpose of this 8-K filing is to reaffirm Elevance Health's (formerly Anthem, Inc.) financial guidance for the full year 2021 and to inform investors about the company's expectations during upcoming investor meetings.

Elevance Health reaffirmed its net income guidance for the full year 2021 to be greater than $24.89 per share. This figure includes approximately $0.61 per share of net unfavorable items. Excluding these items, the company expects adjusted net income to be greater than $25.50 per share.

No, this filing does not introduce new financial information or changes to guidance. It reiterates previously communicated expectations and does not include any adjustments beyond those already reported in the company's second quarter 2021 earnings release.

Yes, the filing explicitly states that it contains forward-looking statements that are subject to significant risks and uncertainties. These could cause actual results to differ materially from the projections. Investors are strongly encouraged to review the company's other SEC filings for a detailed discussion of these risks.